TTGinseng

TTGinseng (TTG Co., Ltd.) is a South Korean biotechnology company specializing in the production of rare ginsenosides through advanced enzyme conversion technology. The company focuses on transforming common ginsenosides found in Panax ginseng into highly bioactive rare forms, such as Compound K, Rg3, and Rh2, which exhibit significantly enhanced absorption and therapeutic potential. These rare ginsenosides are utilized in the nutraceutical, functional food, and pharmaceutical industries for their anti-cancer, anti-inflammatory, and neuroprotective properties. By leveraging its proprietary bioconversion platform, TTGinseng provides standardized, high-purity ingredients to global health markets. The company's mission is to bridge traditional herbal medicine with modern biotechnology to provide scientifically validated health solutions.